SML3983
BAY 2686013
≥98% (HPLC)
别名:
2-amino-N-(4-((3,5-bis(trifluoromethyl)benzyl)oxy)phenyl)acetamide hydrochloride
InChI
1S/C17H14F6N2O2.ClH/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)9-27-14-3-1-13(2-4-14)25-15(26)8-24;/h1-7H,8-9,24H2,(H,25,26);1H
InChI key
LDIQEQUVXGCYRE-UHFFFAOYSA-N
SMILES string
O=C(CN)NC(C=C1)=CC=C1OCC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2.Cl
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
Orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
Disclaimer
Hygroscopic
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Gernot Langer et al.
Molecular pharmacology, 104(3), 105-114 (2023-06-23)
The human pituitary adenylate cyclase-activating polypeptide receptor (hPAC1-R), a class B G-protein-coupled receptor (GPCR) identified almost 30 years ago, represents an important pharmacological target in the areas of neuroscience, oncology, and immunology. Despite interest in this target, only a very
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持